Skip to main content
SpringerLink
Log in

Diagnosed by PET

  • Chapter
  • First Online:
Positron Emission Tomography with Computed Tomography (PET/CT)

  • 2115 Accesses

Abstract

This is a 41-year-old male who presents with a left lateral neck mass. Biopsy shows metastatic non-small cell carcinoma. CT scan of the neck and nasopharynx shows an enlarged left lower internal jugular chain node and soft tissue fullness in the left pyriform.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Calabrese L, Jereczek-Fossa BA, Jassem J, et al. Diagnosis and management of neck metastases from an unknown primary. Acta Otorhinolaryngol Ital. 2005;25:2–12.

    CAS  PubMed Central  PubMed  Google Scholar 

  2. Aasar OS, Fischbein NJ, Caputo GR, et al. Metastatic head and neck cancer : role and usefulness of FDG PET in locating occult primary tumors. Radiology. 1999;210:177–81.

    Article  Google Scholar 

  3. Adams S, Baum RP, Stuckensen T, et al. Prospective comparison of FDG-PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998;25:1255–60.

    Article  CAS  PubMed  Google Scholar 

  4. Chen YK, Cheng RH, Chi KW. Application of FDG PET/CT in nasopharyngeal carcinoma. Ann Nucl Med Sci. 2007;20:21–32.

    Google Scholar 

  5. Fernandez-Cotarelo MJ, Guerra-Vales JM, Colina F, de la Cruz J. Prognostic factors in cancer of unknown primary site. Tumori. 2010;96(1):111–6.

    PubMed  Google Scholar 

  6. Greven KM, Keyes Jr JW, Williams III DW, et al. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D- glucose. Cancer. 1999;86(1):114–8.

    Article  CAS  PubMed  Google Scholar 

  7. Nannic C, Rubelloa D, Fanti S, et al. Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer. Biomed Pharmacother. 2006;60:409–13.

    Article  Google Scholar 

  8. Macapinlac HA. Clinical usefulness of FDG PET in differentiated thyroid cancer. J Nucl Med. 2001;42:77–8.

    CAS  PubMed  Google Scholar 

  9. Ryu SI, Tafti BA, Skirboll SL. Pituitary adenomas can appear as hypermetabolic lesions in (18) F-FDG PET imaging. J Neuroimaging. 2010;20(4):393–6.

    Article  PubMed  Google Scholar 

  10. Erasmus JJ, Patz Jr EF, McAdams HP, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol. 1997;168:1357–60.

    Article  CAS  PubMed  Google Scholar 

  11. Yasuda S, Fujii H, Nakahara T. 18F-FDG PET detection of colonic adenomas. J Nucl Med. 2001;42(7):989–92.

    CAS  PubMed  Google Scholar 

  12. Co JMIO, Villa ML, Santiago JY. Patients with thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography. Phil J Intern Med. 2009;47:71–5.

    Google Scholar 

  13. Van den Bruel A, Maes A, De Potter T, et al. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab. 2002;87(4):1517–20.

    Article  PubMed  Google Scholar 

  14. Sanjay M. Solitary pulmonary nodule imaging. Medscape. 2013. Retrieved from http://emedicine.medscape.com/article/362787-overview.

  15. Swensen SJ, Vigglano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology. 2000;214:73–80.

    Article  CAS  PubMed  Google Scholar 

  16. O JH, Yoo IeR, Kim SH, Sohn HS, Chung SK. Clinical significance of small pulmonary nodules with little or no F18 FDG uptake on PET/CT images of patients with nonthoracic malignancies. J Nucl Med. 2007;48:15–21.

    CAS  PubMed  Google Scholar 

  17. Winer-Muram HT. The solitary pulmonary nodule. Radiology. 2006;239:34–49.

    Article  PubMed  Google Scholar 

  18. Dewan NA, Gupta NC, Redepenning LS, et al. Diagnostic efficacy of PET-FDG in solitary pulmonary nodules. Potential role in evaluation and management. Chest. 1993;104:997–1002.

    Article  CAS  PubMed  Google Scholar 

  19. Antoch G, Stattaus J, Nemat AT, et al. Non small cell lung cancer: dual modality PET-CT in preoperative staging. Radiology. 2003;229:526–33.

    Article  PubMed  Google Scholar 

  20. Christensen JA, Nathan MA, Mullan BP, et al. Characterization of the solitary pulmonary nodule: FDG-PET versus nodule enhancement CT. AJR Am J Roentgenol. 2006;187(5):1361–7.

    Article  PubMed  Google Scholar 

  21. Albert RH, Russell JJ. Evaluation of the solitary pulmonary nodule. Am Fam Physician. 2009;80:827–31.

    PubMed  Google Scholar 

  22. Iwata M, Kasagi K, Misaki T, et al. Comparison of whole body FDG-PET, Tc99m MIBI SPET and post therapeutic I131 scintigraphy in the detection of metastatic thyroid cancer. Eur J Nucl Med Mol Imaging. 2004;31:491–8.

    Article  CAS  PubMed  Google Scholar 

  23. Palmedo H, Bucerius J, Joe A, et al. Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. J Nucl Med. 2006;47:616–24.

    PubMed  Google Scholar 

  24. Wang W, Larson SM, Fazzari M, et al. Prognostic value of F18-fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab. 2000;85:1107–13.

    CAS  PubMed  Google Scholar 

  25. Gambhir S, Czernin J, Schwimmer J, et al. A tabulated summary of the FDG PET literature. J Nucl Med. 2001;42:1S–93.

    CAS  PubMed  Google Scholar 

  26. Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumours using fluorine-18-fluorodeoxyglucose PET: characterization of tumour and assessment of effect of treatment. J Nucl Med. 1992;33:333–9.

    CAS  PubMed  Google Scholar 

  27. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology. 1998;28:751–5.

    Article  Google Scholar 

  28. Santiago JFY, Ongkeko ES, Ogbac RV, et al. The utility of 18F-FDG PET in the evaluation of patients with inoperable hepatocellular carcinoma treated with trans-arterial rhenium-188-conjugated lipiodol therapy. 2007, unpublished.

    Google Scholar 

  29. Torizuka T, Tamaki N, Inokuma T, et al. Value of fluorine-18-FDG PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med. 1994;35:1965–9.

    CAS  PubMed  Google Scholar 

  30. Vitola J, Delbeke D, Meranze S, et al. Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer. 1996;78:2216–21.

    Article  CAS  PubMed  Google Scholar 

  31. Antoch G, Vogt FM, Veit P, et al. Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med. 2005;46:520–5.

    PubMed  Google Scholar 

  32. Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med. 2005;46:1356–67.

    PubMed  Google Scholar 

  33. Moog F, Kotzerke J, Reske SN. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med. 1999;40:1407–13.

    CAS  PubMed  Google Scholar 

  34. Costelloe CM, Chuang HH, Madewell JE. FDG PET for the detection of bone metastases: sensitivity, specificity and comparison with other imaging modalities. PET Clin. 2010;5:281–95.

    Article  Google Scholar 

  35. Ozülker T, Küçüköz Uzun A, Ozülker F, Ozpaçac T. Comparison of 18F-FDG-PET/CT with 99mTc-MDP bone scintigraphy for the detection of bone metastases in cancer patients. Nucl Med Commun. 2010;31:597–603.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and PET Center, St. Luke’s Medical Center, Taguig City, MM, Philippines

    Jonas Francisco Y. Santiago

Authors
  1. Jonas Francisco Y. Santiago
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Santiago, J.F.Y. (2015). Diagnosed by PET. In: Positron Emission Tomography with Computed Tomography (PET/CT). Springer, Cham. https://doi.org/10.1007/978-3-319-05518-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-05518-3_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-05517-6

  • Online ISBN: 978-3-319-05518-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation